Research Progress of Collapse Response Mediator Proteins in Neurodegenerative Diseases

Dev Neurosci. 2022;44(6):429-437. doi: 10.1159/000523875. Epub 2022 Mar 4.

Abstract

Collapse response mediator proteins (CRMPs) are a family of cytoplasmic phosphorylated proteins, and the mechanism of action has always been the research focus of neurological diseases. Previous studies on the CRMPs family have revealed that CRMPs mediate the growth and development of neuronal cytoskeleton through different signaling pathways in the body. It plays an important role in neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and spinocerebellar ataxia, which has attracted the attention of researchers. This article reviews the recent literature on the biological characteristics and mechanisms of CRMPs in different neurodegenerative diseases.

Keywords: Collapse response mediator proteins; Cytoskeleton; Neurite; Neurodegenerative diseases; Signal pathway.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Nerve Tissue Proteins / metabolism
  • Neurodegenerative Diseases* / metabolism
  • Neurons / metabolism

Substances

  • Nerve Tissue Proteins